AC023590.1 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
AC129492.6 | | | ![](/images/43676/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43676/97231_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
AIM2 | Absent in melanoma 2 | | ![](/images/31365/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31365/67667_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
ARHGAP25 | Rho GTPase activating protein 25 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35346/70558_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ATP12A | ATPase, H+/K+ transporting, nongastric, alpha polypeptide | Enzymes Plasma proteins Predicted membrane proteins
| ![](/images/39526/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39526/83655_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
AURKB | Aurora kinase B | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| ![](/images/5862/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/5862/ihc_cell_selected_60x60.jpg) | ![](/images/5862/15412_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | Plasma proteins Transcription factors
| ![](/images/51384/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51384/117261_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37002/84229_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
BFSP2 | Beaded filament structural protein 2, phakinin | Disease related genes
| ![](/images/38464/ihc_selected_60x60.jpg) | ![](/images/38464/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38464/84002_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/1198/2772_A_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
BTN1A1 | Butyrophilin, subfamily 1, member A1 | Predicted membrane proteins
| ![](/images/11126/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11126/28101_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CCL19 | Chemokine (C-C motif) ligand 19 | Cancer-related genes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CCL20 | Chemokine (C-C motif) ligand 20 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5067/13768_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CCL22 | Chemokine (C-C motif) ligand 22 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CCR6 | Chemokine (C-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14488/33886_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
CD180 | CD180 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3740/11072_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CD1C | CD1c molecule | CD markers Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CD22 | CD22 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/24353/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2418/6099_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2420/6095_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD3D | CD3d molecule, delta (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13055/32209_A_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/43955/119468_A_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD3G | CD3g molecule, gamma (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17520/39922_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
CD40LG | CD40 ligand | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | ![](/images/45827/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45827/105628_A_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2497/6307_A_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2489/if_selected_60x60.jpg) | | ![](/images/2489/6143_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/19/ihc_cell_selected_60x60.jpg) | ![](/images/19/395_A_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/9178/26322_A_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD80 | CD80 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25368/56075_B_1_8_rna_selected_60x60.jpg) | Tissue enhanced |
CDC20 | Cell division cycle 20 | Cancer-related genes Plasma proteins
| | | ![](/images/4525/ihc_cell_selected_60x60.jpg) | ![](/images/4525/11549_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CH17-132F21.1 | Uncharacterized protein | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48721/116197_B_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
CHI3L2 | Chitinase 3-like 2 | Plasma proteins Predicted secreted proteins
| ![](/images/5443/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5443/15196_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CLEC4C | C-type lectin domain family 4, member C | CD markers Predicted membrane proteins
| ![](/images/29432/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29432/60663_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CLECL1 | C-type lectin-like 1 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CPNE5 | Copine V | Plasma proteins
| | ![](/images/31369/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31369/65514_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CSF2RB | Colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| ![](/images/10251/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10251/25609_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/469/2664_B_6_6_rna_selected_60x60.jpg) | Tissue enhanced |
CTB-133G6.1 | | Predicted membrane proteins
| ![](/images/49151/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49151/127172_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CXCR4 | Chemokine (C-X-C motif) receptor 4 | Cancer-related genes CD markers Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CYTIP | Cytohesin 1 interacting protein | | ![](/images/7191/ihc_selected_60x60.jpg) | ![](/images/7191/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7191/22828_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
DEFB103A | Defensin, beta 103A | Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
DEFB103B | Defensin, beta 103B | Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
DTX1 | Deltex homolog 1 (Drosophila) | | ![](/images/51249/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51249/116028_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
ELL3 | Elongation factor RNA polymerase II-like 3 | | | | ![](/images_static/rna_center.gif) | ![](/images/28938/89483_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
EML6 | Echinoderm microtubule associated protein like 6 | | ![](/images/62808/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62808/141254_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
FAIM3 | Fas apoptotic inhibitory molecule 3 | Predicted membrane proteins Predicted secreted proteins
| ![](/images/3910/ihc_selected_60x60.jpg) | ![](/images/3910/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3910/11161_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
FAM111B | Family with sequence similarity 111, member B | Disease related genes
| ![](/images/38637/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/38637/81792_B_5_3_rna_selected_60x60.jpg) | Tissue enhanced |
FAM72C | Family with sequence similarity 72, member C | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
FAM72D | Family with sequence similarity 72, member D | | ![](/images/43271/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43271/107367_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |